Join Us!
What are the benefits of accurately assessing plaque burden in your patients with suspected coronary artery disease (CAD)? Listen to two cardiologists discuss the advantages of using a coronary CTA pathway along with AI-based plaque analysis and physiology to understand a patient’s risks of cardiovascular events. They present the recently released 7-year data from ADVANCE-DK that investigates long-term prognosis in stable chest pain patients and discuss how this can better inform more personalized and effective treatment plans.
Learn from our experts about:
- The role of CCTA as a first-line pathway for CAD diagnosis
- How CT-based AI plaque analysis is informing patient care
- How long-term data from ADVANCE-DK informs the importance of plaque analysis in risk assessment and how it applies to real world use
- Actionable benefits physicians see from using plaque analysis
- 2025 Medicare plaque analysis coverage updates and increases in CCTA reimbursement that support this pathway for patient care
Who should watch:
- Cardiologists
- Interventional Cardiologists
- General Practitioners
- NPs
- PAs
- CV Nurses
- Cardiovascular Imaging Specialists
- Cardiovascular Service Line Directors
- Cath Lab Directors
- CT Technologists
Expert Presenters:
Michael Gallagher, MD, FACC |
Kristian Taekker Madsen, MD, PhD |
